Timmermans P B, Van Zwieten P A
Eur J Pharmacol. 1980 May 2;63(2-3):199-202. doi: 10.1016/0014-2999(80)90446-x.
The antagonism by yohimbine (1 mg/kg, i.v.) of vasopressor responses in pithed rats was most pronounced towards B-HT 933 (dose ratio 18.3) and moderate towards clonidine (dose ratio 3.7) and especially L-phenylephrine (dose ratio 2.5). Prazosin (0.1 mg/kg, i.v.) had no effect on the pressor responses to B-HT 933, moderately affected those to clonidine (dose ratio 3.9), but strongly diminished those to L-phenylephrine (dose ratio 53). Phentolamine (1 mg/kg, i.v.) was devoid of a differential antagonism. The results obtained suggest a subclassification of postsynaptic alpha-adrenoceptors into alpha 1- and alpha 2-subtypes mediating pressor effects. B-HT 933 is a selective agonist and yohimbine an antagonist of postsynaptic alpha 2-adrenoceptors. L-Phenylephrine preferably stimulates and prazosin preferentially occupies the alpha 1-adrenoceptors. Clonidine is a potent agonist of both types and phentolamine behaves as a non-selective antagonist.
育亨宾(1毫克/千克,静脉注射)对脊髓麻醉大鼠升压反应的拮抗作用,对B-HT 933最为显著(剂量比为18.3),对可乐定中等(剂量比为3.7),对去氧肾上腺素尤其轻微(剂量比为2.5)。哌唑嗪(0.1毫克/千克,静脉注射)对B-HT 933的升压反应无影响,对可乐定的反应有中等程度影响(剂量比为3.9),但对去氧肾上腺素的反应有强烈抑制作用(剂量比为53)。酚妥拉明(1毫克/千克,静脉注射)无差异拮抗作用。所得结果表明,介导升压作用的突触后α-肾上腺素能受体可细分为α1和α2亚型。B-HT 933是突触后α2-肾上腺素能受体的选择性激动剂,育亨宾是拮抗剂。去氧肾上腺素主要刺激α1-肾上腺素能受体,哌唑嗪优先占据该受体。可乐定是这两种受体的强效激动剂,酚妥拉明表现为非选择性拮抗剂。